Precipio (NASDAQ:PRPO) Stock Crosses Above 200 Day Moving Average – Time to Sell?

Shares of Precipio, Inc. (NASDAQ:PRPO) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $6.16 and traded as high as $7.49. Precipio shares last traded at $7.38, with a volume of 6,502 shares changing hands.

Precipio Price Performance

The company’s 50-day simple moving average is $6.17 and its two-hundred day simple moving average is $6.19. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.73 and a quick ratio of 0.60. The firm has a market capitalization of $10.92 million, a P/E ratio of -4.03 and a beta of 1.42.

Institutional Trading of Precipio

An institutional investor recently bought a new position in Precipio stock. Renaissance Technologies LLC bought a new position in Precipio, Inc. (NASDAQ:PRPO) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 10,100 shares of the biotechnology company’s stock, valued at approximately $56,000. Renaissance Technologies LLC owned approximately 0.68% of Precipio at the end of the most recent quarter. Institutional investors and hedge funds own 10.45% of the company’s stock.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.